ProPhase Labs, Inc.
ProPhase Labs, Inc. (PRPH) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0000868278 · PRPH · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0000868278 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
ProPhase Labs, Inc. (NASDAQ: PRPH) has submitted 916 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1994. As a Healthcare sector company with CIK 0000868278, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is ProPhase Labs, Inc.'s most comprehensive regulatory disclosure. The most recent ProPhase Labs, Inc. 10-K was filed on 2026-06-01 for fiscal year ending 2026. Historical PRPH 10-K annual reports are available from 1996 through 2026.
Investors researching ProPhase Labs, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
PRPH SEC Filings · 8 questionsProPhase Labs, Inc. (PRPH) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 916 filings and access original documents at no cost. ProPhase Labs, Inc.'s CIK is 0000868278.